High Risk Of Injury Or Death Associated With Insulin Infusion Sets Used With Tandem Pumps
Maryland: The tubing used to subcutaneously deliver insulin from a Tandem Diabetes Care pump is among the latest devices to land in the FDA’s hot seat. Unomedical A/S began a recall…
Gujarat FDCA Takes Action Against 11 Companies For Non-Compliance To Norms
Mumbai: The Gujarat Food and Drug Control Administration (FDCA) has taken regulatory measures against eleven pharmaceutical companies located in Bharuch, Baroda, Ahmedabad, and Gandhinagar. Collaborating with the Drugs Controller General…
DCC Recommends SLAs To Take Part In MvPI And Submit ADRs To IPC
New Delhi: The State Licensing Authorities (SLAs) across the country need to take part in the Materiovigilance Programme of India (MvPI) and submit the Adverse Drug Reaction (ADR) reports of materiovigilance…
Gujarat FDCA Soon To Make NCC & PC Available Online Before VGGS-2024
Mumbai: The Gujarat Food and Drugs Control Administration (FDCA) is all set to make Non-Conviction Certificates (NCC) and Performance Certificates (PC) for pharma companies available online before the 10th Vibrant…
Pharma Groups Fight Proposed Ban On Titanium Dioxide In Europe
Amsterdam: Pharmaceutical industry groups are working to submit comments to the European Medicines Agency (EMA) to oppose a proposed ban on the use of titanium dioxide (TiO2) in Europe. The…
DCC Recommends To DCGI Inclusion Of Details Of All Excipients In QR Code For Top 300 Brands
New Delhi: The Drugs Consultative Committee (DCC) of the Union health ministry has recommended to the national drug regulator to amend the regulation mandating Quick Response (QR) code for the top…
Indian Immunologicals Rolls Out Measles, ‘Mabella’ Rubella Vaccine For Kids
Hyderabad: Vaccine maker Indian Immunologicals Ltd (IIL) on Saturday launched its measles and rubella (MR) vaccine – Mabella – for children. The live attenuated MR vaccine has been developed by Indian…
OTC Drugs For Fungal Infections Can Harm
LUCKNOW: Taking over-the-counter drugs for fungal infections could worsen the problem, as these medications often contain steroids that can further hinder the body’s ability to fight off the infection, cautioned medical…
Cost-Effective Drugs For 14 Rare Diseases, To Be Launched Soon: Mansukh Mandaviya
NEW DELHI: The centre on Friday announced that India-made drugs for 14 rare diseases, which afflict 6-8 per cent of India’s population, will be available soon. Apart from 13 rare diseases,…
Industry Must Bring In More Money Into Pharma R&D: DCGI
New Delhi: The Drug Controller General of India (DCGI) Rajeev Raghuvansh on Thursday said that India has all the ingredients of a mature pharmaceutical market from infrastructure to fresh talent and…
